Home/Pipeline/TEXAGEN® Amniotic Membrane Allograft

TEXAGEN® Amniotic Membrane Allograft

Wound and Surgical Repair

Approved/CommercialMarketed

Key Facts

Indication
Wound and Surgical Repair
Phase
Approved/Commercial
Status
Marketed
Company

About Sanara MedTech

Sanara MedTech is a Texas-based medical technology company with a mission to improve clinical outcomes and reduce healthcare expenditures through transformative surgical and wound care products. The company has successfully commercialized a portfolio of regenerative medicine products for soft tissue repair and surgical site management, establishing a revenue-generating foundation. Its strategic focus is now on advancing its flagship OsStic™ bone bioadhesive technology, a high-potential platform with FDA Breakthrough Device Designation, while leveraging its commercial infrastructure for growth.

View full company profile